To use all functions of this page, please activate cookies in your browser.
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Directive 65/65/EEC1Directive 65/65/EEC1 was the first European pharmaceutical directive. The directive was a reaction to the Thalidomide tragedy in the early 1960s, when thousands of babies were born with deformities as a result of their mothers taking thalidomide during pregnancy. The directive aimed to establish and maintain a high level of protection for public health in Europe.[citation needed] The idea behind the directive was that no medicinal product should ever again be marketed in the European Union without prior authorisation.[citation needed] Additional recommended knowledgeSee alsoReferences
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Directive_65/65/EEC1". A list of authors is available in Wikipedia. |